ScholarIQanswers from OpenAlex

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

PaperCitations, authors & open-access status

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment have?

ScholarIQcitation count

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment has 339 citations in the OpenAlex counts ScholarIQ stores.

When was Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment published?

ScholarIQyear

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment has 2015 year in the ScholarIQ index.

What is the open-access status of Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment?

ScholarIQoa status

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment has closed oa status in the ScholarIQ index.

What is the DOI of Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment?

ScholarIQdoi

The DOI for Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment is on the source record.

What is the PMID of Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment?

ScholarIQpmid

The PMID for Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment is on the source record.

What is the OpenAlex record for Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment?

ScholarIQopenalex

The OpenAlex for Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial